Clinical Trials Browser

INDUSTRY × Interventional × lenzilumab × Clear all

NCT02546284 2020-02-28

Study of Lenzilumab in Previously Treated Patients With Chronic Myelomonocytic Leukemia (CMML)

Phase 1 Completed

Other hematologic neoplasm

Leukemia, Myelomonocytic, Chronic